Oncogene news from around the world

Federal government invests $30.8M to advance precision oncology for adults with cancer through ‘Precision Oncology Screening Platform Enabling Clinical Trials’ – PrOSPeCT
Omico welcomes the Federal Government’s significant $143.4 million investment in world-leading precision oncology programs—the Zero…